LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.

Other languages Luoxin Pharmaceuticals Group Stock Co., Ltd.

Equities

002793

CNE1000026S7

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 28/05/2024 BST			5-day change	1st Jan Change
4.92 ^CNY	-1.01%		+0.20%	-8.21%

04-26	Luoxin Pharmaceuticals Group Stock Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-08	Luoxin Pharma Gets Right to Use Shenzhen Shishijijun Biotechnology's Fecal Microbiota Transplant Technology	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Luoxin Pharmaceuticals Group Stock Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-26
Luoxin Pharma Gets Right to Use Shenzhen Shishijijun Biotechnology's Fecal Microbiota Transplant Technology	03-08
Luoxin Pharmaceuticals Group Stock Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.	02-01
Luoxin Pharmaceuticals Group Stock Co., Ltd. authorizes a Buyback Plan.	01-31
Luoxin Pharmaceuticals Posts Positive Results of Plucanatide Tablets' Trial	01-29
Two Luoxin Pharma Drugs Selected in China’s National Drug Procurement Program	11-17
Luoxin Pharmaceuticals Group Stock Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23
Luoxin Pharmaceuticals Group Stock Co., Ltd.'s LX-039 (Innovative Anti-Tumor Drug) Phase I Clinical Study Data Presented At ESMO 2023	23/10/23
Luoxin Pharmaceuticals Group Stock Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23
Luoxin Pharmaceuticals Group Stock Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23
Luoxin Pharmaceuticals Group Stock Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27/04/23
Luoxin Pharmaceuticals Group Stock Co., Ltd. Elects Li Meng as Non-Independent Directors	01/02/23
Luoxin Pharmaceuticals' Injection Passes Regulatory Consistency Evaluation	11/01/23
Luoxin Pharmaceuticals Gets Regulatory Nod for Anti-Baterial Infection Drug	28/12/22
Luoxin Pharmaceuticals Group Stock Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	28/10/22
Luoxin Pharmaceuticals Unit Plans to Sell Stake in Medical Equipment Firm	21/09/22
Luoxin Pharmaceuticals Group Stock Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	29/08/22
Luoxin Pharmaceuticals Group Stock Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2021, Payable on May 13, 2022	09/05/22
Luoxin Pharmaceuticals Group Stock Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	29/04/22
Luoxin Pharmaceuticals Group Stock Co., Ltd. Approves Cash Dividend	28/03/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Luoxin Pharmaceuticals Group Stock Co., Ltd.

Equities

002793

CNE1000026S7

Other languages

Filters